30 |
Chang F.-Y., Chuang Y.C., Veeraraghavan B., Apisarnthanarak A., Tayzon M.F., Kwa A.L., Chiu C.-H., Deris Z.Z., Amir Husin S., Hashim H., Karuniawati A., Ahmed A., Matsumoto T., Nguyen V.K., Dinh T.T.H. |
Gaps in antimicrobial stewardship programmes in Asia: a survey of 10 countries |
2022 |
JAC-Antimicrobial Resistance |
|
Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan; Medical Research Department, Chi Mei Medical Center, Tainan City, Taiwan; Department of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India; Department of Medicine, Thammasat University Hospital, Pathum Thani, Thailand; Department of Medicine, Section of Infectious Diseases, Hospital Infection Control and Epidemiology Center, Medical City, Pasig City, Philippines; Department of Pharmacy, Singapore General Hospital, Singapore, Singapore; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore, Singapore; Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Medical Microbiology and Parasitology, School of Medical Sciences, Hospital Universiti Sains Malaysia, USM Health Campus, Kubang Kerian, Kelantan, Malaysia; Medical Development Division, Ministry of Health, Putrajaya, Malaysia; Pharmacy Practice and Development Division, Ministry of Health, Petaling Jaya, Malaysia; Department of Microbiology, Medical Faculty, Universitas Indonesia, Jakarta, Indonesia; Department of Pathology/Microbiology, Pakistan Kidney and Liver Institute, Lahore, Pakistan; Department of Infectious Diseases, International University of Health and Welfare, Chiba-ken, Japan; Infectious Diseases Department, Hanoi Medical University, Hanoi, Viet Nam; Emergency Department - Infection Control, National Hospital for Tropical Diseases, Hanoi, Viet Nam |
Pfizer |
Oxford University Press |
#N/A |
|
|